Opaleye Management Inc. Avalo Therapeutics, Inc. Transaction History

Opaleye Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.0 - $10.45 $3.01 Million - $10.5 Million	-1,004,400 Reduced 69.06%	450,000 $225,000
Q1 2022 May 16, 2022	SELL	$7.57 - $21.72 $37,850 - $108,600	-5,000 Reduced 0.34%	1,454,400 $1.05 Million
Q3 2021 Nov 16, 2021	BUY	$26.16 - $40.68 $38.2 Million - $59.4 Million	1,459,400 New	1,459,400 $3.18 Million

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $91.6M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.